The startup has developed an AI-driven image analysis tool that objectively classifies and predicts oocyte quality, embryo viability, and uterine lining conditions. This technology enables clinicians to create personalized treatment plans, improving patient outcomes in reproductive health.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MVFounders
Product
Problem
In assisted reproductive technology (ART), the lack of objective methods for assessing oocyte quality leads to uncertainty in treatment planning and patient counseling. Traditional oocyte assessment relies on subjective visual inspection, which has limited predictive power for fertilization success and embryo development. This can result in multiple unsuccessful IVF cycles and increased emotional and financial burden for patients.
Solution
Future Fertility offers AI-powered image analysis tools that provide objective, personalized insights into oocyte quality, embryo viability, and uterine lining conditions. The company's VIOLET™ and MAGENTA™ reports analyze microscopic images of oocytes using machine learning algorithms trained on a large dataset of oocyte images with known outcomes. These tools generate a score for each egg, predicting its likelihood of developing into a viable blastocyst and leading to a live birth. By providing clinicians and patients with quantitative data on egg quality, Future Fertility enables more informed decision-making in fertility treatment, potentially improving success rates and reducing the need for multiple cycles. The MyFutureFertility™ platform provides patients with secure access to their egg quality reports, empowering them to actively participate in their fertility journey.
Target Audience
The primary target audience includes fertility clinics, reproductive endocrinologists, embryologists, and IVF patients seeking objective and personalized insights into oocyte quality to improve treatment planning and outcomes.
Features
- AI-driven image analysis of oocytes to predict blastocyst development and ploidy status
- VIOLET™ reports for egg freezing, providing a probability of successful pregnancy with frozen eggs
- MAGENTA™ reports for IVF, offering a score correlating to each egg's chance of forming a high-quality blastocyst
- Non-invasive assessment requiring only a photo of each egg after retrieval
- MyFutureFertility™ platform for secure patient access to personalized egg quality reports
- Clinically validated tools, with findings published in peer-reviewed journals
- Integration with existing lab workflows, providing objective insights without disrupting current processes
- Euploidy assessment to determine the potential of eggs to create embryos with the correct number of chromosomes (available in some reports)